CALC

CalciMedica, Inc. Common Stock

NASDAQ: CALC · HEALTHCARE · BIOTECHNOLOGY

$0.63

+24.62% today

Updated 2026-06-05

Market cap

$12.89M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.31

Dividend yield

—

52W range

$0 – $7

Volume

1.5M

Market cap

$12.89M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.31

Dividend yield

—

52W range

$0 – $7

Volume

1.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

3.8

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-25.5

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →205 stocks currently score above 75

Price targets

Analyst target

$10.33

+1539.16%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -25.47 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-4.86M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-7.82M	$-34.36M	$-13.70M	$-29.56M	$4.98M
EPS	—	—	—	—	$-1.31
Free cash flow	$-11.76M	$-25.81M	$-21.15M	$-21.21M	$-4.86M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CALC	$12.89M	19	4.3	3.0	5.0	3.8	—	Avoid
LLY	$1.08T	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$613.02B	57	4.7	9.0	3.3	6.0	-87.08%	Buy
ABBV	$447.62B	63	4.0	8.0	4.7	5.0	-73.27%	Buy
UNH	$388.59B	54	5.3	5.5	4.0	5.5	-33.19%	Buy
NVS	$296.54B	49	3.3	9.0	3.3	4.5	-69.70%	Hold

Smart narrative

CalciMedica, Inc. Common Stock trades at $0.63. Our Smart Value Score of 19/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -25.47, it sits in the distress.

Frequently asked questions

What is CalciMedica, Inc. Common Stock's stock price?

CalciMedica, Inc. Common Stock (CALC) trades at $0.63.

Is CalciMedica, Inc. Common Stock overvalued?

CalciMedica, Inc. Common Stock carries a Smart Value Score of 19/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of CalciMedica, Inc. Common Stock (CALC)?

The 12-month analyst consensus target is $10.33, about 1539.2% above the current $0.63. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

CalciMedica, Inc. Common Stock's Altman Z-Score is -25.47, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-399.50%

Beta1.24

50D MA$0.71

200D MA$2.31

Shares out0.02B

Float0.01B

Short ratio—

Avg volume1.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CALC vs LLY →CALC vs JNJ →CALC vs ABBV →Stock screener →